1. Far upstream element‐binding protein 1 confers lobaplatin resistance by transcriptionally activating PTGES and facilitating the arachidonic acid metabolic pathway in osteosarcoma
   Qiong Ma et al, 2023, MedComm CrossRef
2. The circACTN4 interacts with FUBP1 to promote tumorigenesis and progression of breast cancer by regulating the expression of proto-oncogene MYC
   Xiaosong Wang et al, 2021, Molecular Cancer CrossRef
3. Mass spectroscopy-based proteomics and metabolomics analysis of triple-positive breast cancer cells treated with tamoxifen and/or trastuzumab
   Basma M. Sharaf et al, 2022, Cancer Chemotherapy and Pharmacology CrossRef
4. Combination of Immune-Related Network and Molecular Typing Analysis Defines a Three-Gene Signature for Predicting Prognosis of Triple-Negative Breast Cancer
   Jinguo Zhang et al, 2022, Biomolecules CrossRef
5. MRI-based breast cancer radiogenomics using RNA profiling: association with subtypes in a single-center prospective study
   Ah Young Park et al, 2023, Breast Cancer Research CrossRef
6. Far upstream element -binding protein 1 (FUBP1) participates in the malignant process and glycolysis of colon cancer cells by combining with c-Myc
   Shanwei Wang et al, 2022, Bioengineered CrossRef
7. A novel fatty-acid metabolism-based classification for triple negative breast cancer
   Xia Yang et al, 2023, Aging CrossRef
8. Evaluating the efficacy and microenvironment changes of HER2 + gastric cancer during HLX02 and Endostar treatment using quantitative MRI
   Jianye Liang et al, 2022, BMC Cancer CrossRef